Summary

Global Autoimmune Disease Diagnostics Market 2024-2028
The autoimmune disease diagnostics market is forecasted to grow by USD 2,988.16 mn during 2023-2028, accelerating at a CAGR of 9.59% during the forecast period. The report on the autoimmune disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in laboratory automation platforms, discovery of novel biomarkers leading to improved autoimmune disease diagnosis, and increasing M and A activities among market vendors.
Technavio's autoimmune disease diagnostics market is segmented as below:
By Type
• Localized autoimmune disease diagnostics
• Systemic autoimmune disease diagnostics
By Product
• Assay kits
• Analyzer
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the focus on companion diagnostic tests as one of the prime reasons driving the autoimmune disease diagnostics market growth during the next few years. Also, a shift from monoplex to multiplex testing and a growing preference for direct-to-consumer testing will lead to sizable demand in the market.
The report on the autoimmune disease diagnostics market covers the following areas:
• Autoimmune disease diagnostics market sizing
• Autoimmune disease diagnostics market forecast
• Autoimmune disease diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoimmune disease diagnostics market vendors that include Autoimmune Technologies LLC, Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, Exagen Inc., F. Hoffmann La Roche Ltd., Gold Standard Diagnostics Corp., Grifols SA, Hemagen Diagnostics Inc., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, Immco Diagnostics Inc., Laboratory Corp. of America Holdings, PerkinElmer Inc., Quest Diagnostics Inc., R Biopharm AG, Siemens AG, Svar Life Science AB, Thermo Fisher Scientific Inc., and Werfenlife SA. Also, the autoimmune disease diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/autoimmune-disease-diagnostics-market-industry-analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global autoimmune disease diagnostics market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global autoimmune disease diagnostics market 2018 - 2022 ($ million)
o 4.2 Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
o 4.3 Product Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Localized autoimmune disease diagnostics - Market size and forecast 2023-2028
o Exhibit 34: Chart on Localized autoimmune disease diagnostics - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Localized autoimmune disease diagnostics - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Localized autoimmune disease diagnostics - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Localized autoimmune disease diagnostics - Year-over-year growth 2023-2028 (%)
o 6.4 Systemic autoimmune disease diagnostics - Market size and forecast 2023-2028
o Exhibit 38: Chart on Systemic autoimmune disease diagnostics - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Systemic autoimmune disease diagnostics - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Systemic autoimmune disease diagnostics - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Systemic autoimmune disease diagnostics - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 44: Chart on Product - Market share 2023-2028 (%)
o Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
o 7.2 Comparison by Product
o Exhibit 46: Chart on Comparison by Product
o Exhibit 47: Data Table on Comparison by Product
o 7.3 Assay kits - Market size and forecast 2023-2028
o Exhibit 48: Chart on Assay kits - Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Assay kits - Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Assay kits - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Assay kits - Year-over-year growth 2023-2028 (%)
o 7.4 Analyzer - Market size and forecast 2023-2028
o Exhibit 52: Chart on Analyzer - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Analyzer - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Analyzer - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Analyzer - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Product
o Exhibit 56: Market opportunity by Product ($ million)
o Exhibit 57: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 UK - Market size and forecast 2023-2028
o Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.9 Germany - Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.10 Canada - Market size and forecast 2023-2028
o Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Bio Rad Laboratories Inc.
o Exhibit 107: Bio Rad Laboratories Inc. - Overview
o Exhibit 108: Bio Rad Laboratories Inc. - Business segments
o Exhibit 109: Bio Rad Laboratories Inc. - Key news
o Exhibit 110: Bio Rad Laboratories Inc. - Key offerings
o Exhibit 111: Bio Rad Laboratories Inc. - Segment focus
o 12.4 bioMerieux SA
o Exhibit 112: bioMerieux SA - Overview
o Exhibit 113: bioMerieux SA - Product / Service
o Exhibit 114: bioMerieux SA - Key offerings
o 12.5 Danaher Corp.
o Exhibit 115: Danaher Corp. - Overview
o Exhibit 116: Danaher Corp. - Business segments
o Exhibit 117: Danaher Corp. - Key news
o Exhibit 118: Danaher Corp. - Key offerings
o Exhibit 119: Danaher Corp. - Segment focus
o 12.6 DiaSorin SpA
o Exhibit 120: DiaSorin SpA - Overview
o Exhibit 121: DiaSorin SpA - Business segments
o Exhibit 122: DiaSorin SpA - Key news
o Exhibit 123: DiaSorin SpA - Key offerings
o Exhibit 124: DiaSorin SpA - Segment focus
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 125: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 126: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 127: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 128: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 129: F. Hoffmann La Roche Ltd. - Segment focus
o 12.8 Grifols SA
o Exhibit 130: Grifols SA - Overview
o Exhibit 131: Grifols SA - Business segments
o Exhibit 132: Grifols SA - Key offerings
o Exhibit 133: Grifols SA - Segment focus
o 12.9 Hemagen Diagnostics Inc.
o Exhibit 134: Hemagen Diagnostics Inc. - Overview
o Exhibit 135: Hemagen Diagnostics Inc. - Product / Service
o Exhibit 136: Hemagen Diagnostics Inc. - Key offerings
o 12.10 HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
o Exhibit 137: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview
o Exhibit 138: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product / Service
o Exhibit 139: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings
o 12.11 Laboratory Corp. of America Holdings
o Exhibit 140: Laboratory Corp. of America Holdings - Overview
o Exhibit 141: Laboratory Corp. of America Holdings - Business segments
o Exhibit 142: Laboratory Corp. of America Holdings - Key news
o Exhibit 143: Laboratory Corp. of America Holdings - Key offerings
o Exhibit 144: Laboratory Corp. of America Holdings - Segment focus
o 12.12 PerkinElmer Inc.
o Exhibit 145: PerkinElmer Inc. - Overview
o Exhibit 146: PerkinElmer Inc. - Business segments
o Exhibit 147: PerkinElmer Inc. - Key news
o Exhibit 148: PerkinElmer Inc. - Key offerings
o Exhibit 149: PerkinElmer Inc. - Segment focus
o 12.13 Quest Diagnostics Inc.
o Exhibit 150: Quest Diagnostics Inc. - Overview
o Exhibit 151: Quest Diagnostics Inc. - Business segments
o Exhibit 152: Quest Diagnostics Inc. - Key offerings
o Exhibit 153: Quest Diagnostics Inc. - Segment focus
o 12.14 R Biopharm AG
o Exhibit 154: R Biopharm AG - Overview
o Exhibit 155: R Biopharm AG - Product / Service
o Exhibit 156: R Biopharm AG - Key offerings
o 12.15 Siemens AG
o Exhibit 157: Siemens AG - Overview
o Exhibit 158: Siemens AG - Business segments
o Exhibit 159: Siemens AG - Key news
o Exhibit 160: Siemens AG - Key offerings
o Exhibit 161: Siemens AG - Segment focus
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 162: Thermo Fisher Scientific Inc. - Overview
o Exhibit 163: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 164: Thermo Fisher Scientific Inc. - Key news
o Exhibit 165: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 166: Thermo Fisher Scientific Inc. - Segment focus
o 12.17 Werfenlife SA
o Exhibit 167: Werfenlife SA - Overview
o Exhibit 168: Werfenlife SA - Product / Service
o Exhibit 169: Werfenlife SA - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 170: Inclusions checklist
o Exhibit 171: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 172: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 173: Research methodology
o Exhibit 174: Validation techniques employed for market sizing
o Exhibit 175: Information sources
o 13.5 List of abbreviations
o Exhibit 176: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global autoimmune disease diagnostics market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Localized autoimmune disease diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Localized autoimmune disease diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Localized autoimmune disease diagnostics - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Localized autoimmune disease diagnostics - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Systemic autoimmune disease diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Systemic autoimmune disease diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Systemic autoimmune disease diagnostics - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Systemic autoimmune disease diagnostics - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Product - Market share 2023-2028 (%)
Exhibits45: Data Table on Product - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Product
Exhibits47: Data Table on Comparison by Product
Exhibits48: Chart on Assay kits - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Assay kits - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Assay kits - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Assay kits - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Analyzer - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Analyzer - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Analyzer - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Analyzer - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Product ($ million)
Exhibits57: Data Table on Market opportunity by Product ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Bio Rad Laboratories Inc. - Overview
Exhibits108: Bio Rad Laboratories Inc. - Business segments
Exhibits109: Bio Rad Laboratories Inc. - Key news
Exhibits110: Bio Rad Laboratories Inc. - Key offerings
Exhibits111: Bio Rad Laboratories Inc. - Segment focus
Exhibits112: bioMerieux SA - Overview
Exhibits113: bioMerieux SA - Product / Service
Exhibits114: bioMerieux SA - Key offerings
Exhibits115: Danaher Corp. - Overview
Exhibits116: Danaher Corp. - Business segments
Exhibits117: Danaher Corp. - Key news
Exhibits118: Danaher Corp. - Key offerings
Exhibits119: Danaher Corp. - Segment focus
Exhibits120: DiaSorin SpA - Overview
Exhibits121: DiaSorin SpA - Business segments
Exhibits122: DiaSorin SpA - Key news
Exhibits123: DiaSorin SpA - Key offerings
Exhibits124: DiaSorin SpA - Segment focus
Exhibits125: F. Hoffmann La Roche Ltd. - Overview
Exhibits126: F. Hoffmann La Roche Ltd. - Business segments
Exhibits127: F. Hoffmann La Roche Ltd. - Key news
Exhibits128: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits129: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits130: Grifols SA - Overview
Exhibits131: Grifols SA - Business segments
Exhibits132: Grifols SA - Key offerings
Exhibits133: Grifols SA - Segment focus
Exhibits134: Hemagen Diagnostics Inc. - Overview
Exhibits135: Hemagen Diagnostics Inc. - Product / Service
Exhibits136: Hemagen Diagnostics Inc. - Key offerings
Exhibits137: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview
Exhibits138: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product / Service
Exhibits139: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings
Exhibits140: Laboratory Corp. of America Holdings - Overview
Exhibits141: Laboratory Corp. of America Holdings - Business segments
Exhibits142: Laboratory Corp. of America Holdings - Key news
Exhibits143: Laboratory Corp. of America Holdings - Key offerings
Exhibits144: Laboratory Corp. of America Holdings - Segment focus
Exhibits145: PerkinElmer Inc. - Overview
Exhibits146: PerkinElmer Inc. - Business segments
Exhibits147: PerkinElmer Inc. - Key news
Exhibits148: PerkinElmer Inc. - Key offerings
Exhibits149: PerkinElmer Inc. - Segment focus
Exhibits150: Quest Diagnostics Inc. - Overview
Exhibits151: Quest Diagnostics Inc. - Business segments
Exhibits152: Quest Diagnostics Inc. - Key offerings
Exhibits153: Quest Diagnostics Inc. - Segment focus
Exhibits154: R Biopharm AG - Overview
Exhibits155: R Biopharm AG - Product / Service
Exhibits156: R Biopharm AG - Key offerings
Exhibits157: Siemens AG - Overview
Exhibits158: Siemens AG - Business segments
Exhibits159: Siemens AG - Key news
Exhibits160: Siemens AG - Key offerings
Exhibits161: Siemens AG - Segment focus
Exhibits162: Thermo Fisher Scientific Inc. - Overview
Exhibits163: Thermo Fisher Scientific Inc. - Business segments
Exhibits164: Thermo Fisher Scientific Inc. - Key news
Exhibits165: Thermo Fisher Scientific Inc. - Key offerings
Exhibits166: Thermo Fisher Scientific Inc. - Segment focus
Exhibits167: Werfenlife SA - Overview
Exhibits168: Werfenlife SA - Product / Service
Exhibits169: Werfenlife SA - Key offerings
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations